Channels - A potential multimodal biomarker – cognitive signature associated with the conversion from subjective cognitive decline to mild cognitive impairment

Similar Items: A potential multimodal biomarker – cognitive signature associated with the conversion from subjective cognitive decline to mild cognitive impairment

Quick Look
Refining cognitive dispersion metrics for brain–behavior prediction in aging and mild cognitive impairment
Quick Look
Virtual reality-based cognitive assessment tools for mild cognitive impairment screening: comparison with traditional paper-and-pencil-based cognitive assessment tools
Quick Look
Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment
Quick Look
Vascular cognitive impairment and dementia drug‐development pipeline 2025
Quick Look
Cognitive dispersion in established adulthood: etiology and implications for cognitive aging
Quick Look
Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
Quick Look
Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
Quick Look
Determinants of Medical Help–Seeking Behavior Following Case Finding of Early Cognitive Impairment: Semistructured Interview Study of Patients and Caregivers
Quick Look
Associations of plasma p‐Tau217 with cognitive domain performance in clinically unimpaired participants: Evidence from HABS‐HD
Quick Look
Life-course socioeconomic trajectories and cognitive aging in Chinese middle-aged and older adults
Quick Look
Sarcopenia and Its Relationships with Depression, Cognition, and Physical Activity in Thai Community-Dwelling Older Adults
Quick Look
A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
Quick Look
Travel and mind: a bidirectional analysis of travel participation and cognitive functioning among Americans over 50
Quick Look
Single‐subject proteomic signatures in Alzheimer's disease reflect clinical phenotypes and distinguish asymptomatic from symptomatic cases
Quick Look
The I‐Learn Cognition and Behavior program for non‐pharmacological treatment of agitation in nursing home residents with neurocognitive disorders: A cluster randomized trial
Quick Look
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
Quick Look
Virtual reality‐based cognitive‐motor training in middle‐aged adults at high Alzheimer's disease risk improves frontal cortex cerebral blood flow: A randomized controlled trial
Quick Look
Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
Quick Look
Comparison of Two Frailty Assessment Methods and Their Association with Functionality in Subjects with Exacerbation of COPD
Quick Look
Physical activity attenuates the association between allostatic load and early Alzheimer's disease‐related biomarkers in older adults
Quick Look
Prevalence and Factors Associated with Impairment in Intrinsic Capacity among Community-Dwelling Older Adults: An Observational Study from South India
Quick Look
Biomarkers of Sarcopenia: Current Status and Future Perspectives
Quick Look
Visual Impairment and Handgrip Strength in Aging: Evidence from Bidirectional Mendelian Randomization
Quick Look
Investigating the amyloid–tau–neurodegeneration framework in Alzheimer's disease using semi‐supervised multimodal imaging data fusion